Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing Life Science Investing
Fulgent Selected to Present Rapid Oral Abstract Within the Head and Neck Cancer Track Session at the 2026 ASCO Annual Meeting Life Science Investing
Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026 Medical Device Investing
Gilead Sciences to Release First Quarter 2026 Financial Results on Thursday, May 7, 2026 Life Science Investing
AMGEN ANNOUNCES RETIREMENT OF DAVID M. REESE, EXECUTIVE VICE PRESIDENT AND CHIEF TECHNOLOGY OFFICER Life Science Investing
PTC Showcases Bobcat's Use of the Intelligent Product Lifecycle at Hannover Messe 2026 Life Science Investing
Tempest Announces Key Manufacturing Milestone for TPST-2003 Dual-Targeting CD19/BCMA CAR-T Life Science Investing
